LU62332A1 - - Google Patents

Info

Publication number
LU62332A1
LU62332A1 LU62332DA LU62332A1 LU 62332 A1 LU62332 A1 LU 62332A1 LU 62332D A LU62332D A LU 62332DA LU 62332 A1 LU62332 A1 LU 62332A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU62332A1 publication Critical patent/LU62332A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13Tumour cells, irrespective of tissue of origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20211Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU62332D 1969-12-31 1970-12-28 LU62332A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (de) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
LU62332A1 true LU62332A1 (de) 1971-05-27

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
LU62332D LU62332A1 (de) 1969-12-31 1970-12-28

Country Status (11)

Country Link
JP (1) JPS4940922B1 (de)
AT (1) AT301749B (de)
BE (1) BE760727A (de)
CA (1) CA956573A (de)
CH (1) CH533988A (de)
DE (1) DE2064296C2 (de)
DK (1) DK128054B (de)
FR (1) FR2073293B1 (de)
GB (1) GB1326928A (de)
LU (1) LU62332A1 (de)
NL (1) NL7019097A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (de) * 1976-08-20 1978-03-16
CH664494A5 (it) * 1979-10-11 1988-03-15 Liborio Dott Bonifacio Procedimento per preparare antidoti per la prevenzione e la cura dei tumori, dagli escrementi delle capre.
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Also Published As

Publication number Publication date
AT301749B (de) 1972-09-11
DE2064296C2 (de) 1984-10-25
NL7019097A (de) 1971-07-02
CA956573A (en) 1974-10-22
DE2064296A1 (de) 1971-07-15
FR2073293B1 (de) 1973-01-12
FR2073293A1 (de) 1971-10-01
JPS4940922B1 (de) 1974-11-06
BE760727A (fr) 1971-05-27
DK128054B (da) 1974-02-25
CH533988A (fr) 1973-02-28
GB1326928A (en) 1973-08-15

Similar Documents

Publication Publication Date Title
AU2270770A (de)
AU4221168A (de)
FR2073293B1 (de)
AU2355770A (de)
AU427401B2 (de)
AU414607B2 (de)
AU470661B1 (de)
AT308690B (de)
AU428129B2 (de)
AU428074B2 (de)
AU410358B2 (de)
AU425297B2 (de)
AU428131B2 (de)
AU417208B2 (de)
AR203167Q (de)
AU5133369A (de)
AU4923469A (de)
AU1036070A (de)
AU5066368A (de)
CH551651A (de)
BE729927A (de)
CH572968A5 (de)
CH579548A5 (de)
AU3648969A (de)
AU3858369A (de)